Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05796518 · ClinicalTrials.gov registry record · NA
Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT05796518 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 44 participants.
The verdict
NCT05796518, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
Investigators are conducting this study to find out more about what heart health means to participants and how healthcare providers can best help to manage heart health. Participants will be asked to view an electronic tool designed to promote heart health awareness and help to manage heart health outside of the clinic. This study will provide important information to help investigators develop future programs that improve cancer patient's heart health after they complete their treatment.
Interventions
- OTHER Survey
- OTHER PREVENT Cardiovascular Health Assessment Tool
- OTHER Interview Regarding Heart Health
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2023-09-07 |
| Est. Completion | 2024-06-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05796518
The ClinicalTrials.gov registry entry for NCT05796518 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Survey is the first listed.
NCT05796518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05796518 about?
NCT05796518 is a clinical study titled "Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors". Investigators are conducting this study to find out more about what heart health means to participants and how healthcare providers can best help to manage heart health. Participants will be asked to view an electronic tool designed to promote heart health awareness and help to manage heart health o...
What is the current status of trial NCT05796518?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2023-09-07. Estimated completion is 2024-06-07.
What interventions are being tested in trial NCT05796518?
The interventions under investigation include: Survey (OTHER), PREVENT Cardiovascular Health Assessment Tool (OTHER), Interview Regarding Heart Health (OTHER).
Who is sponsoring clinical trial NCT05796518?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.